In a groundbreaking development, the University of Houston has secured $3M to establish a state-of-the-art Cancer Immunotherapy Biomarker Core facility. This cutting-edge facility is set to revolutionize biomarker discovery, enhance immunotherapy targeting, and bolster research capabilities throughout Texas. By boosting the state’s standing in cancer research, this initiative promises to drive advancements in patient outcomes […]